查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1747680

全球人造骨市场

Artificial Bones
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 177 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球人造骨市场规模将达24亿美元

全球人造骨市场规模预计在2024年为18亿美元，预计到2030年将达到24亿美元，2024年至2030年的复合年增长率为5.7%。陶瓷材料是本报告分析的细分市场之一，预计其复合年增长率为4.5%，到分析期结束时市场规模将达到8.357亿美元。复合材料细分市场在分析期间的复合年增长率预计为7.2%。

美国市场规模估计为 4.61 亿美元，中国市场预计复合年增长率为 5.6%

预计到2024年，美国骨替代市场规模将达到4.61亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到3.931亿美元，在2024-2030年的分析期间内，复合年增长率为5.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.9%和5.1%。在欧洲，预计德国市场的复合年增长率为4.7%。

全球人造骨市场－主要趋势与驱动因素摘要

为什么人工骨骼对于整形外科、创伤和重组外科的进步至关重要？

人工骨是合成或生物工程製成的替代物，用于替换、修復和强化受损或缺失的骨组织。它们在整形外科、创伤照护、牙齿重组、肿瘤相关骨缺损治疗等领域日益重要。随着人口老化、高强度衝击损伤以及骨质疏鬆症和骨关节炎等慢性疾病导致全球骨相关疾病发病率上升，对可靠且生物相容性的骨植体的需求持续飙升。

在创伤和整形外科手术中，骨替代物可作为支架，促进骨再生、填补结构空隙并恢復动态完整性。这些替代物通常用于天然骨移植不足或不切实际的情况，例如脊椎融合手术、长骨骨折修復、关节重组以及复杂的翻修手术。与自体和同种异体骨移植相比，骨替代物可降低供体部位的发生率，消除疾病传播的风险，并且可扩展使用，因此极具价值，尤其是在高容量的医疗保健系统和急诊外科环境中。

人工骨用于颚颜面手术、颅骨缺损修復和人工植牙等重组应用，这些应用着重精准度、骨整合和美观。 3D列印和客製化形状的骨植体正日益广泛应用，以改善解剖贴合度、缩短手术时间并提升术后功能。随着外科技术的进步和患者期望值的提高，人工骨解决方案正从被动填充材发展成为现代肌肉骨骼护理中主动的生物整合组件。

材料创新、生物整合和积层製造如何改变产品性能？

材料科学是人工骨骼发展的核心。传统的磷酸钙基材料，例如羟基磷灰石和磷酸三钙，因其生物相容性和骨传导性而备受推崇。然而，生物活性玻璃、聚合物-陶瓷复合材料和奈米结构支架等新型复合材料则具有更高的机械强度、可控制的吸收速率和卓越的生物相互作用。这些创新使人工骨更适用于承重和非承重应用。

生物整合是关键的进展领域，工程骨产品融合了生长因子、干细胞和表面改性，以促进骨诱导和血管化。采用重组骨生成激素(rhBMP) 和富血小板血浆 (PRP) 涂层的产品促进了骨再生，尤其是在复杂或无法癒合的缺损中。表面纹理和图形化也透过改善细胞黏附性和促进与宿主组织的整合，使植入具有更强的生理响应性。

积层製造（3D列印）正在彻底改变患者客製化人工骨植入物的生产方式。利用CT和MRI影像数据，外科医师和工程师可以设计出符合个体骨骼结构的解剖学精确模型，最大限度地减少术中调整，并最大限度地提高动态力学相容性。这些客製化植入由钛、PEEK或生物陶瓷材料製成，目前已用于颅脑、脊椎和整形外科肿瘤手术。随着製造成本的降低和监管途径的简化，3D列印骨替代物有望成为个人化整形外科治疗的标准。

哪些临床领域和地理市场正在推动人工骨解决方案的采用？

整形外科仍然是骨假体最大的临床应用领域，尤其是在脊椎融合手术、骨折修復和关节重新置换置换术方面。由于全球人口老化和骨质疏鬆症相关骨折发生率的上升，医疗保健系统正在优先考虑微创解决方案，以减少住院时间并促进更快康復。在脊椎和创伤外科手术中，骨假体通常与金属固定装置一起使用，以提高癒合率并稳定结构完整性。

牙科和颚颜面外科也是一个高成长领域，其驱动力源于牙周治疗、植入固定以及拔牙后齿槽窝保存对移植骨替代物的需求。由于合成骨填充剂无菌、易于操作且吸收性稳定，牙科专业人员越来越多地采用合成骨填充材。在肿瘤学领域，它们用于保肢手术和肿瘤切除后的重组手术，尤其是在传统骨移植选择有限的儿童和老年患者中。

从地区来看，北美和欧洲凭藉其先进的外科基础设施、完善的报销制度以及生物和3D列印移植技术的早期应用，引领市场。亚太地区正经历快速成长，这得益于医疗服务可及性的扩大、医疗旅游的兴起以及中国、印度、日本和韩国整形外科手术数量的不断增加。拉丁美洲和中东是新兴市场，在这些地区，官民合作关係和整形外科推广计画正在推动创伤和重组医学领域采用经济高效的合成移植替代方案。

不断发展的法规、临床证据和成本绩效指标如何影响竞争策略？

美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构正在不断更新指南，以确保工程骨产品的安全性、有效性和品管。循证核准的转变正在鼓励製造商投资长期临床试验和上市后监测，以检验在不同患者群体中的效果。关于生物增强型移植物和个人化植入的新兴监管法规也在简化创新流程，同时确保临床医生和患者对新解决方案的信心。

优化性价比仍然是骨假体应用的关键决定因素。医院和采购机构会根据操作的便利性、整合速度、手术效果以及与自体移植和同种异体移植的比较价格来评估骨假体。提供模组化移植系统、临床医生培训和疗效追踪的製造商已获得竞争优势，尤其是在价格敏感的医疗保健环境中。基于价值的医疗保健模式正在提升那些能够降低再手术率、加快康復速度并降低总护理成本的产品的重要性。

器械製造商、生物技术公司和研究机构之间的策略伙伴关係正在加速下一代人造骨骼的开发。这些联盟正在推动智慧骨植入的创新，这些植入物融合了生物感测器、药物传输功能和再生涂层。在日益激烈的竞争中，品牌建立、外科医生忠诚度计画和差异化的临床支援服务正成为成熟地区和新兴地区市场定位的核心。

哪些因素推动了人造骨市场的成长？

由于人口老化、整形外科技术创新以及对安全、可扩展的自体移植替代品的需求，人工骨市场正在迅速扩张。随着全球对骨缺损、创伤和重组的需求日益增长，人工骨为各种外科手术提供了可靠、多功能的解决方案。其能够减少併发症、消除供体部位併发症并加快恢復时间，越来越符合现代外科手术和经济效益的优先考虑。

材料、生物整合和病患客製化的产品创新正在重塑竞争动态，并拓展临床适应症。监管环境、外科医生的认可度以及研发开发平臺的投资正在强化商业化格局。随着医疗保健系统寻求经济高效、以结果为导向的整形外科解决方案，人工骨骼正逐渐成为下一代肌肉骨骼疗法的基石。

展望未来，市场发展轨迹将取决于人工骨技术与个人化医疗、再生疗法和数数位化手术工作流程的有效组合。随着生物智慧和功能自适应植入的需求日益增长，人工骨能否发展成为智慧支架，不仅能够取代人体骨骼结构，还能主动再生和修復？

部分

材料（陶瓷、复合材料、聚合物、羟基磷灰石、其他材料）、应用（脊椎融合、牙科、颅颚颜面、关节重组、创伤/四肢）、最终用户（医院、专科诊所、研究/学术机构）

受访公司范例（总合37家）

  • AlloSource
  • Baxter International Inc.
  • Biogennix
  • Biomatlante
  • Bone Support AB
  • Cowellmedi Co., Ltd.
  • Curasan AG
  • DePuy Synthes（Johnson & Johnson）
  • DSM Biomedical
  • Epibone
  • Geistlich Pharma AG
  • Graftys SA
  • Kuros Biosciences AG
  • LifeNet Health
  • Mathys Ltd Bettlach
  • Maxigen Biotech Inc.
  • Medtronic plc
  • NovaBone Products, LLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP34623

Global Artificial Bones Market to Reach US$2.4 Billion by 2030

The global market for Artificial Bones estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Ceramics Material, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$835.7 Million by the end of the analysis period. Growth in the Composite Material segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$461.0 Million While China is Forecast to Grow at 5.6% CAGR

The Artificial Bones market in the U.S. is estimated at US$461.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$393.1 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Artificial Bones Market - Key Trends & Drivers Summarized

Why Are Artificial Bones Becoming Integral to Orthopedic, Trauma, and Reconstructive Surgical Advancements?

Artificial bones are synthetic or biologically engineered substitutes designed to replace, repair, or augment damaged or missing bone tissue. They are increasingly vital across orthopedic surgery, trauma care, dental reconstruction, and oncology-related bone defect treatments. As the global incidence of bone-related disorders rises-driven by aging populations, high-impact injuries, and chronic conditions such as osteoporosis and osteoarthritis-demand for reliable, biocompatible bone substitutes continues to surge.

In trauma and orthopedic procedures, artificial bones serve as scaffolds to promote bone regeneration, fill structural voids, and restore biomechanical integrity. These substitutes are often used in spinal fusion, long bone fracture repair, joint reconstruction, and complex revision surgeries where natural bone grafts may be insufficient or impractical. Compared to autografts or allografts, artificial bones reduce donor site morbidity, eliminate disease transmission risk, and offer scalable availability-making them particularly valuable in high-volume healthcare systems and emergency surgical environments.

In reconstructive applications, artificial bones are employed in maxillofacial surgery, cranial defect repairs, and dental implants, where precision, osseointegration, and aesthetic outcomes are paramount. 3D-printed and custom-shaped bone substitutes are increasingly being used to enhance anatomical fit, reduce surgical time, and improve post-operative functionality. As surgical techniques advance and patient expectations rise, artificial bone solutions are evolving from passive fillers to active bio-integrative components of modern musculoskeletal care.

How Are Material Innovations, Biologic Integration, and Additive Manufacturing Transforming Product Capabilities?

Material science is at the core of artificial bone evolution. Traditional calcium phosphate-based materials-such as hydroxyapatite and tricalcium phosphate-are valued for their biocompatibility and osteoconductivity. However, newer composite materials, including bioactive glass, polymer-ceramic hybrids, and nanostructured scaffolds, are offering enhanced mechanical strength, controlled resorption rates, and superior biological interaction. These innovations are making artificial bones more adaptable across load-bearing and non-load-bearing applications.

Biologic integration is a key area of advancement, with artificial bone products now incorporating growth factors, stem cells, and surface modifications to enhance osteoinduction and vascularization. Products featuring recombinant bone morphogenetic proteins (rhBMPs) or platelet-rich plasma (PRP) coatings are accelerating bone regeneration, particularly in complex or non-healing defects. Surface texturing and nano-patterning are also improving cell adhesion and promoting faster host tissue integration, making the implants more physiologically responsive.

Additive manufacturing (3D printing) is revolutionizing the production of patient-specific artificial bone implants. Using CT or MRI imaging data, surgeons and engineers can design anatomically precise models that conform to individual bone structures, minimizing intraoperative adjustments and maximizing biomechanical compatibility. These customized implants-manufactured from titanium, PEEK, or bioceramic materials-are being adopted in cranial, spinal, and orthopedic oncology surgeries. As production costs decrease and regulatory pathways streamline, 3D-printed bone substitutes are expected to become standard practice in personalized orthopedic care.

Which Clinical Segments and Regional Markets Are Driving Adoption of Artificial Bone Solutions?

Orthopedic surgery remains the largest clinical segment for artificial bones, particularly in spinal fusion, fracture repair, and joint revision procedures. With an aging global population and rising rates of osteoporosis-related fractures, healthcare systems are prioritizing minimally invasive solutions that reduce hospital stay and promote faster recovery. In spine and trauma surgery, artificial bones are commonly used alongside metal fixation devices to enhance fusion rates and stabilize structural integrity.

Dental and maxillofacial surgery is another high-growth segment, driven by demand for bone graft substitutes in periodontal treatment, implant anchorage, and post-extraction socket preservation. Dental professionals are increasingly adopting synthetic bone fillers due to their sterility, ease of handling, and consistent resorption profiles. In oncology, artificial bones are used in limb-sparing procedures and post-tumor resection reconstructions, particularly for pediatric and geriatric patients where traditional graft options may be limited.

Regionally, North America and Europe lead the market due to advanced surgical infrastructure, strong reimbursement frameworks, and early adoption of biologic and 3D-printed graft technologies. Asia-Pacific is experiencing rapid growth, supported by expanding healthcare access, medical tourism, and a rising volume of orthopedic procedures in China, India, Japan, and South Korea. Latin America and the Middle East are emerging markets where public-private partnerships and orthopedic outreach programs are driving the adoption of cost-effective synthetic graft alternatives across trauma and reconstructive care.

How Are Regulatory Evolution, Clinical Evidence, and Cost-Performance Metrics Influencing Competitive Strategy?

Regulatory bodies such as the FDA and EMA are continuously updating guidelines to ensure safety, efficacy, and quality control for artificial bone products. The shift toward evidence-based approvals is prompting manufacturers to invest in long-term clinical trials and post-market surveillance to validate performance in diverse patient populations. Regulatory clarity around biologically enhanced grafts and personalized implants is also streamlining innovation while ensuring clinician and patient confidence in new solutions.

Cost-performance optimization remains a key determinant of adoption. Hospitals and procurement agencies are evaluating artificial bones based on handling ease, integration speed, surgical outcomes, and comparative pricing versus autografts and allografts. Manufacturers that offer modular graft systems, clinician training, and outcome tracking are gaining a competitive edge, especially in price-sensitive healthcare settings. Value-based healthcare models are amplifying the importance of products that reduce revision rates, accelerate recovery, and lower total care costs.

Strategic partnerships among device manufacturers, biotech firms, and research institutions are accelerating the development of next-generation artificial bones. These collaborations are fostering innovation in smart bone implants that incorporate biosensors, drug-delivery functions, or regenerative coatings. With competition intensifying, branding, surgeon loyalty programs, and differentiated clinical support services are becoming central to market positioning across both mature and emerging regions.

What Are the Factors Driving Growth in the Artificial Bones Market?

The artificial bones market is expanding rapidly, driven by the convergence of aging demographics, orthopedic innovation, and demand for safe, scalable alternatives to autologous grafts. As the global burden of bone defects, trauma injuries, and reconstructive needs grows, artificial bones offer a reliable, versatile solution across a wide range of surgical interventions. Their ability to reduce complications, eliminate donor-site morbidity, and shorten recovery times is increasingly aligned with modern surgical and economic priorities.

Product innovation in materials, biologic integration, and patient-specific customization is reshaping competitive dynamics and expanding clinical indications. Regulatory backing, surgeon acceptance, and investment in R&D pipelines are strengthening the commercialization landscape. As healthcare systems seek cost-effective, outcomes-driven orthopedic solutions, artificial bones are emerging as a cornerstone of next-generation musculoskeletal treatment.

Looking ahead, the market’s trajectory will depend on how effectively artificial bone technologies integrate with personalized medicine, regenerative therapies, and digitized surgical workflows. As demand for biologically intelligent and functionally adaptive implants rises, could artificial bones evolve into smart scaffolds that not only replace but actively regenerate and restore human skeletal structures?

SCOPE OF STUDY:

The report analyzes the Artificial Bones market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Ceramics, Composite, Polymer, Hydroxyapatite, Other Materials); Application (Spinal Fusion, Dental, Craniomaxillofacial, Joint Reconstruction, Trauma & Extremities); End-User (Hospitals, Specialty Clinics, Research & Academic Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 37 Featured) -

  • AlloSource
  • Baxter International Inc.
  • Biogennix
  • Biomatlante
  • Bone Support AB
  • Cowellmedi Co., Ltd.
  • Curasan AG
  • DePuy Synthes (Johnson & Johnson)
  • DSM Biomedical
  • Epibone
  • Geistlich Pharma AG
  • Graftys SA
  • Kuros Biosciences AG
  • LifeNet Health
  • Mathys Ltd Bettlach
  • Maxigen Biotech Inc.
  • Medtronic plc
  • NovaBone Products, LLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Bones - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Trauma, Fractures, and Orthopedic Disorders Throws the Spotlight on Artificial Bone Implants
    • Growth in Minimally Invasive and Reconstructive Surgeries Spurs Demand for Biocompatible Bone Substitutes
    • OEM Advancements in 3D Printing and Scaffold Engineering Strengthen Customization of Synthetic Bone Designs
    • Increased Use of Calcium Phosphate and Hydroxyapatite Compounds Enhances Integration With Natural Bone
    • Adoption in Dental Implants and Craniofacial Surgery Expands Scope Beyond Large Orthopedic Reconstructions
    • Surge in Geriatric Population and Osteoporosis Cases Drives Market for Bone Void Fillers
    • Expansion of Bioactive and Growth Factor-Infused Materials Bodes Well for Accelerated Regeneration
    • Use of Artificial Bones in Trauma Management and Military Medicine Enhances Emergency Response Capabilities
    • Growth in Veterinary Orthopedic Procedures Opens Parallel Demand in Animal Healthcare
    • Global Investment in Biomaterials R&D Supports Innovation in Hybrid and Smart Bone Graft Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Bones Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Bones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Bones by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Ceramics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Composite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Composite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hydroxyapatite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Hydroxyapatite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Trauma & Extremities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Trauma & Extremities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Spinal Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Dental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Dental by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Craniomaxillofacial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Craniomaxillofacial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Joint Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Joint Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • JAPAN
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • CHINA
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • EUROPE
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Bones by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Bones by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • FRANCE
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • GERMANY
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Bones Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by Material - Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Bones by Material - Percentage Breakdown of Value Sales for Ceramics, Composite, Polymer, Hydroxyapatite and Other Materials for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by Application - Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Artificial Bones by Application - Percentage Breakdown of Value Sales for Trauma & Extremities, Spinal Fusion, Dental, Craniomaxillofacial and Joint Reconstruction for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Artificial Bones by End-user - Hospitals, Specialty Clinics and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Artificial Bones by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Research & Academic Institutes for the Years 2025 & 2030

IV. COMPETITION